The Exchange
The Exchange
CNBC
Novo Nosedives, New AI Darlings & Buy the Former High-Flyers? 11/24/25
43 minutes Posted Nov 24, 2025 at 7:46 pm.
0:00
43:44
Download MP3
Show notes
Novo Nordisk hits a 4-year low, just days after rival Eli Lilly hits a $1T market cap milestone.
Plus, some former high-flyers trading more down to earth. Is now the time to get in? And, two unlikely names dominating the AI narrative now.